Search All News
A pilot feasibility study to assess new therapy addresses a critical gap in treatment options for a high-risk patient population with unique emotional needs.
Despite growing evidence of efficacy and safety, however, access to this form of therapy remains largely inaccessible to those who need it the most.
The award recognizes residents who go above and beyond their duties to foster a culture of collaboration and excellence.
A new study suggests that mothers who experience poor sleep during pregnancy, particularly during the second trimester, are more likely to have children with neurodevelopmental issues.
Source:Brookhaven National LaboratorySeptember 17, 2018
“This study strongly indicates the feasibility of using multimodal MRI—particularly diffusion MRI–based analysis of the structural connectome—to accurately predict Alzheimer’s risk,” said Jiook Cha.
Source:NatureSeptember 14, 2018
Dr. Paul Appelbaum et al take a closer look at precision medicine.
Source:InStyleSeptember 13, 2018
“A good deal of the demonization of people with mental disorders stems from a marked overestimation of their risk of violence,” says Dr. Paul Applebaum.
Source:Time MagazineSeptember 13, 2018
Dr. Sander Markx and Dr. Job de Jong are hoping their work on mini brains could lead to a pioneering study using stem cells to find and test new treatments for psychiatric disorders.
- September 13, 2018
Kristina Denisova, PhD specializes in state of the art brain imaging of children at risk for Autism Spectrum Disorders (ASD) at Columbia University Irving Medical Center.
Source:The ConversationSeptember 12, 2018
The Columbia Suicide Severity Rating Scale (C-SSRS) was primarily developed Dr. Kelly Posner as a tool to screen for suicidality in medication research trials.
Source:Digital JournalSeptember 12, 2018
“We are thrilled about our new partners and the opportunity to apply our biotechnology platform at the scale needed to identify new drugs for neuropsychiatric disorders,” said Dr. Sean Escola.
- September 12, 2018
Dr. Mark Olfson discusses his team’s new research, “Insomnia and Impaired Quality of Life in the United States.”